At a glance
- Originator Teva Pharmaceutical Industries
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Neurological disorders
Most Recent Events
- 26 Jun 1998 Discontinued-Preclinical for Neurological disorders in Israel (Unknown route)
- 05 Jun 1998 Preclinical development for Neurological disorders in Israel (Unknown route)